Keay Nakae
Stock Analyst at Chardan Capital
(4.44)
# 312
Out of 5,090 analysts
251
Total ratings
46.09%
Success rate
26.91%
Average return
Main Sectors:
Stocks Rated by Keay Nakae
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARWR Arrowhead Pharmaceuticals | Maintains: Buy | $60 | $61.44 | -2.34% | 22 | Dec 1, 2025 | |
| ALUR Allurion Technologies | Maintains: Neutral | $2.5 | $1.70 | +47.06% | 7 | Nov 20, 2025 | |
| SABS SAB Biotherapeutics | Maintains: Buy | $12 | $3.98 | +201.51% | 18 | Nov 17, 2025 | |
| ABUS Arbutus Biopharma | Maintains: Buy | $5 | $4.42 | +13.12% | 14 | Nov 14, 2025 | |
| COYA Coya Therapeutics | Maintains: Buy | $14 | $6.02 | +132.56% | 22 | Nov 14, 2025 | |
| MNPR Monopar Therapeutics | Maintains: Buy | $100 | $80.38 | +24.41% | 6 | Nov 13, 2025 | |
| OBIO Orchestra BioMed Holdings | Maintains: Buy | $20 | $4.40 | +354.55% | 13 | Nov 13, 2025 | |
| KRRO Korro Bio | Downgrades: Neutral | $25 → $7 | $7.02 | -0.28% | 4 | Nov 13, 2025 | |
| RNA Avidity Biosciences | Maintains: Neutral | $72 | $71.63 | +0.52% | 21 | Nov 11, 2025 | |
| PRQR ProQR Therapeutics | Maintains: Buy | $4 | $2.09 | +91.39% | 16 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 | $6.96 | +402.87% | 13 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $325 → $400 | $458.12 | -12.69% | 14 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $38 | $20.28 | +87.38% | 13 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 | $1.20 | +316.67% | 5 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $1.25 → $6 | $16.66 | -63.99% | 10 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 | $3.85 | +55.84% | 7 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $8 | $0.88 | +809.09% | 10 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.03 | - | 5 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $8 → $6 | $17.87 | -66.42% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,140 → $380 | $5.17 | +7,250.10% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $55 | $11.90 | +362.18% | 10 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.25 → $10 | $4.90 | +104.08% | 5 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $100 → $88 | $19.93 | +339.04% | 2 | Sep 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $0.7 → $13 | $1.22 | +965.57% | 3 | Feb 9, 2021 |
Arrowhead Pharmaceuticals
Dec 1, 2025
Maintains: Buy
Price Target: $60
Current: $61.44
Upside: -2.34%
Allurion Technologies
Nov 20, 2025
Maintains: Neutral
Price Target: $2.5
Current: $1.70
Upside: +47.06%
SAB Biotherapeutics
Nov 17, 2025
Maintains: Buy
Price Target: $12
Current: $3.98
Upside: +201.51%
Arbutus Biopharma
Nov 14, 2025
Maintains: Buy
Price Target: $5
Current: $4.42
Upside: +13.12%
Coya Therapeutics
Nov 14, 2025
Maintains: Buy
Price Target: $14
Current: $6.02
Upside: +132.56%
Monopar Therapeutics
Nov 13, 2025
Maintains: Buy
Price Target: $100
Current: $80.38
Upside: +24.41%
Orchestra BioMed Holdings
Nov 13, 2025
Maintains: Buy
Price Target: $20
Current: $4.40
Upside: +354.55%
Korro Bio
Nov 13, 2025
Downgrades: Neutral
Price Target: $25 → $7
Current: $7.02
Upside: -0.28%
Avidity Biosciences
Nov 11, 2025
Maintains: Neutral
Price Target: $72
Current: $71.63
Upside: +0.52%
ProQR Therapeutics
Nov 4, 2025
Maintains: Buy
Price Target: $4
Current: $2.09
Upside: +91.39%
Aug 8, 2025
Maintains: Buy
Price Target: $35
Current: $6.96
Upside: +402.87%
Aug 1, 2025
Maintains: Buy
Price Target: $325 → $400
Current: $458.12
Upside: -12.69%
Jul 29, 2025
Maintains: Buy
Price Target: $50 → $38
Current: $20.28
Upside: +87.38%
Jun 25, 2025
Maintains: Buy
Price Target: $5
Current: $1.20
Upside: +316.67%
May 8, 2025
Downgrades: Neutral
Price Target: $1.25 → $6
Current: $16.66
Upside: -63.99%
Mar 28, 2025
Maintains: Buy
Price Target: $6
Current: $3.85
Upside: +55.84%
Nov 13, 2024
Maintains: Buy
Price Target: $10 → $8
Current: $0.88
Upside: +809.09%
Feb 9, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.03
Upside: -
Aug 4, 2023
Maintains: Sell
Price Target: $8 → $6
Current: $17.87
Upside: -66.42%
Nov 10, 2022
Maintains: Buy
Price Target: $1,140 → $380
Current: $5.17
Upside: +7,250.10%
Nov 9, 2022
Maintains: Buy
Price Target: $65 → $55
Current: $11.90
Upside: +362.18%
Aug 16, 2022
Maintains: Neutral
Price Target: $1.25 → $10
Current: $4.90
Upside: +104.08%
Sep 20, 2021
Upgrades: Neutral
Price Target: $100 → $88
Current: $19.93
Upside: +339.04%
Feb 9, 2021
Downgrades: Neutral
Price Target: $0.7 → $13
Current: $1.22
Upside: +965.57%